In addition to a strong lineup of presenters, Doheny will also be well represented as SriniVas R. Sadda, MD, closes out his term as president of ARVO at the culmination of the 2025 meeting. Dr. Sadda ...

This article examines the legal implications of AI in healthcare, focusing on liability issues and the need for clear accountability in medical AI applications.

Avant Technologies Inc. (OTCQB:AVAI) (”Avant” or the “Company”), and its partner, Ainnova Tech, Inc., (Ainnova), a leading ...

In diabetes care, AI has propelled the field forward through predictive modeling, decision support, and real-time glycemic ...

Patients with diabetes may not need to have a HbA1c value lower than 8% before cataract surgery to reduce the risk for endophthalmitis.

Pars plana vitrectomy is a safe and effective surgery that is essential in the treatment of a variety of posterior segment ...

Vantage Biosciences has dosed the first subject in the randomised Phase II trial of oral therapy VX-01 to treat ...

Dr. Michael Kapusta, MD, FRSCS, Ophthalmologist, talks about advanced (proliferative) diabetic retinopathy and pars plana ...

Adam Bešić’s life journey began in a small old town by the Una River, in Bosanska Otoka, and today it leads him through ...

Vantage Biosciences, a clinical stage biotechnology company advancing innovative therapies for diabetic eye diseases, today announced that the first patient has been successfully dosed in its Phase 2 ...